Format

Send to

Choose Destination
See comment in PubMed Commons below
Thromb Res. 2010 Aug;126(2):88-92. doi: 10.1016/j.thromres.2010.01.012. Epub 2010 Feb 13.

Use of the Delphi method to facilitate antithrombotics prescription during pregnancy.

Author information

1
Gynaecology-Obstetrics Department, EA3065 (Thrombosis Research Group), University Hospital, 42055 Saint-Etienne Cedex 2, Jean Monnet University, France. celine.chauleur@chu-st-etienne.fr

Abstract

INTRODUCTION:

Management of pregnant women at risk for venous thromboembolism (VTE) remains complex. Guidelines do not definitively fix optimal strategies due to limited trial data. Our objective was to build an easy-to-use tool allowing individualised, risk-adapted prophylaxis.

MATERIALS AND METHODS:

A Delphi exercise was conducted to collect 19 French experts' opinions on pregnancy-related VTE.

RESULTS:

Experts with an active interest in clinical research and care of VTE and placental vascular complications were selected. The risk score was classified by an anonymous computer vote. A scoring system for VTE risk in pregnant women was developed, each score being associated with a specific treatment: graduated elastic compression stockings, aspirin, prophylactic Low Molecular Weight Heparin (LMWH: variable durations), or adjusted-dose of LMWH through pregnancy and postpartum.

CONCLUSIONS:

Our simple consensual scoring system offers an individual estimation of thrombosis risk during pregnancy together with its related therapeutic strategy, in accordance with most of the new international recommendations. The accuracy of our individual risk score-based therapeutic guidance is currently being prospectively evaluated in a multicenter trial.

TRIAL REGISTRATION:

ClinicalTrials.gov NCT00745212.

PMID:
20153880
DOI:
10.1016/j.thromres.2010.01.012
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center